Contract Services Clinical Research
AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significanc...
April 15, 2024 | News
TransThera Sciences, a clinical-stage biopharmaceutical company focused on inventing differentiated drugs for global patients, announced the poster present...
April 15, 2024 | News
NTT Research Foundation funds Fellowship Program in new field of Physics of Intelligence. Field of study bridges computer science, brain science and phy...
April 12, 2024 | News
IBD, or Inflammatory Bowel Disease, traditionally more prevalent in developed nations, is increasingly observed in developing regions like China....
April 11, 2024 | News
ACROBiosystems has been continuously rolling out a series of innovative organoid-related products. At a range of significant international events, includin...
April 11, 2024 | News
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, resear...
April 09, 2024 | News
Cure Brain Cancer Foundation proudly unveiled the launch of its groundbreaking 5-Year Guardian Trust Early Career Fellowship, valued at $575,000. The...
April 08, 2024 | News
This collaboration is set to marry the formidable capabilities of both entities, granting broader access to state-of-the-art genomic technologies, unparall...
April 05, 2024 | News
Invenra Inc., an innovative leader in bispecific antibody technology, is pleased to announce a strategic collaboration with Catalent, a global Contract Dev...
April 03, 2024 | News
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...
April 03, 2024 | News
Baird Medical Devices, Inc. ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China&nb...
April 01, 2024 | News
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced it has entered into ...
March 29, 2024 | News
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a...
March 27, 2024 | News
Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been dosed in Australia in the clinical study (JSKN033-101) of JSKN0...
March 26, 2024 | News
Most Read
Bio Jobs
News
Editor Picks